Open AccessEXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Author(s) -
А. Катапано,
Е. В. Шляхто,
А. И. Мартынов,
Р. Г. Оганов,
В. В. Кухарчук,
Marina V. Shestakova,
А С Аметов,
С. А. Бойцов,
М. Г. Бубнова,
S. Villevalde,
А. С. Галявич,
Ю. А. Карпов,
Ж. Д. Кобалава,
Н. А. Козиолова
Publication year - 2013
Publication title -
kardiovaskulârnaâ terapiâ i profilaktika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 16
eISSN - 2619-0125
pISSN - 1728-8800
DOI - 10.15829/1728-8800-2013-4-75-78
Subject(s) - simvastatin , medicine , ezetimibe , lipid metabolism , kidney disease , disease , pharmacology , endocrinology , cholesterol
Expert Consensus. Role of combination lipid-lowering therapy (simvastatin/ezetimibe 20/10 mg) in the correction of lipid metabolism disturbances in patients with chronic kidney disease.